Whooping Cough Preventable Vaccine Trends and Forecast
The future of the global whooping cough preventable vaccine market looks promising with opportunities in the acellular vaccine and whole-cell vaccine markets. The global whooping cough preventable vaccine market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are the increasing awareness of vaccination importance, the rising incidence of whooping cough globally, and growing advancements in vaccine technology for improved efficacy.
• Lucintel forecasts that, within the type category, 12 months below is expected to witness higher growth over the forecast period.
• Within the application category, acellular vaccine is expected to witness higher growth.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Whooping Cough Preventable Vaccine Market
Further, even the whooping cough preventable vaccine market is experiencing some new trends that will shape the market going forward. Some of these trends are usage of combination vaccination, more campaigns to educate the population, modern methods of vaccination, and more people getting access to vaccines and the rising popularity of vaccinating adults.
• Combination vaccines incorporation: Another prominent development in the whooping cough market other than the barriers is the new vaccine performance combination vaccines. They immunize against several diseases in addition to whooping cough like tetanus and dysphoria. This also helps to ensure that their timeframe is reduced and compliance is enhanced. When more health practitioners use the combination of all necessary vaccines, the rates of immunization will increase and therefore, it is expected that the rate of whooping cough infection and other diseases whose vaccines are available will reduce drastically.
• Increased public awareness campaigns: More public awareness campaigns aimed at improving vaccination of whooping cough is essential. Communities are being educated regarding the danger of the disease and the need to be vaccinated with healthy campaigns for example pregnant women and babies through health authorities. The steps will help address vaccine uptake challenges improving whooping cough control activities hence outbreaks will be experienced.
• Advances in vaccine manufacturing: Advances in vaccine manufacturing have changed the outlook on how whooping cough can be prevented. Adjuvants that increase the immunity of a vaccine and new approaches, for example, the intranasal vaccine delivery system have also been developed. These improvements in technology will in addition to increasing the effective rate of whooping cough vaccines enhance patients’ satisfaction and enhance patients’ compliance with medication. As more and more changes emerge these changes have the possibility of changing the whole picture of vaccination in the world.
• Enhanced availability of vaccines: Vaccine availability must improve so all populations are able to get immunized against whooping cough. There are increasing attempts to build and expand immunization programs in developing countries with the assistance of international health agencies. Addressing vaccine pricing and improving distribution channels are also necessary to get more people to the hard to reach populations. This is beneficial to global vaccination targets aimed at preventing the re-emergence of whooping cough.
• Increasing attention to immunization in adults: In addition, attention seems to be shifting to adult vaccination against whooping cough, especially for caregivers of babies and pregnant women. Health policymakers understand the need to protect adults so that they do not threaten the welfare of the susceptible populations including children. Health officials are embarking on booster vaccination campaigns to boost the defense against whooping cough. This trend helps in applying vaccination to all age groups which in the end better the community’s immune system.
These young trends are rebuilding the whooping cough preventable vaccine market by triggering innovation, raising the health literacy connectome, and increasing the reach. The development of combination vaccines and new technologies will make immunization more effective. Since the campaigns to raise public awareness have been quite a few and now more heads are turning to the issue of adult vaccinations, there is a great likelihood that the rates of vaccination will get considerable boosts which will in the end bring down the incidence of whooping cough and improve public health.
Recent Developments in the Whooping Cough Preventable Vaccine Market
The whooping cough preventable vaccine market is booming with a plethora of new developments whose aim is to enhance the rates of vaccination across the world and the health status of the people. New vaccine formulations, novel immunization techniques, and increasing efforts by public health authorities to raise awareness and accessibility to vaccines are some of the major developments that have been noted. These measures are of great importance because of the re-emergence of whooping cough and are necessary to cover the entire population.
• Introduction of new vaccine formulations: Acellular vaccine development has brought a considerable acceptance of whooping cough in the market. Because of fewer side effects associated with these vaccines, parents and caregivers have shown willingness to accept them. Development of such formulations is paramount in increasing coverage of vaccination and preventing whooping cough from susceptible populations in general.
• Enhanced immunization strategies: Enhanced immunization strategies have been put in place to make sure there are successful contents ever made in the coverage of vaccination for whooping cough. There is an emphasis on high-risk group campaigns for example for infants, and pregnant women and their focus has shifted to the babies as well as pregnant women to receive health care. Additionally, these initiatives include the education of healthcare providers regarding the new ways of vaccination. Adherence to the vaccination schedules will also be enhanced and more people will be protected against whooping cough.
• Increased public health initiatives: Increased public health initiatives help in improving knowledge concerning the disease as well as the preventive measures available through vaccination. Health programs are trying to handle this problem by educating parents about the disease and the need to vaccinate on time. Vaccine promotion campaigns prove useful in overcoming the reluctance towards vaccinations improving vaccine coverage aimed at good community health and averting future whooping cough occurrences.
• Working with other international health organizations: Collaboration with other international health organizations has helped in achieving better vaccine distribution and availability in various low- and middle-income countries. Partnerships with agencies like the WHO and UNICEF are easing vaccine delivery and training of health care providers. Such collaborations are important in curbing the disparities in the delivery of the whooping cough vaccine and even ensuring that all those who need vaccination are availed of the services to help reduce the disease substantially.
• Concentration on assessing and estimating the occurrence of illness: A concentration on assessing and estimating the occurrence of illness due to whooping cough or a large number of cases has become more important in the current vaccine industry. Authorities in health are putting in place mechanisms to monitor the levels of immunization in the population and the prevalence of diseases. Such recommendations not only ensure that outbreaks are controlled within the right timeline, but they also help devise issues on public health. Limiting the focus of surveillance on the public will enhance herd immunity and avoid a situation where whooping cough will reemerge in the communities.
The recent developments in the whooping cough preventable vaccine market have been beneficial to the population as they have increased awareness levels, improved the formulation of the vaccine, and enhanced access to immunization. New vaccines and strategies that are incorporated into vaccination programs have led to higher vaccination coverage and less whooping cough. This is possible with cooperation from global health organizations and fortified surveillance activities towards an all-rounded way of callous management of whooping cough and protection of the population.
Strategic Growth Opportunities for Whooping Cough Preventable Vaccine Market
Several strategic growth opportunities in the whooping cough preventable vaccine market are driven by innovations in the vaccine technology, awareness and changing health care needs. Some of the key growth opportunities that the population can capitalize on include improving access to vaccines, the use of technology for outreach, the construction of combination vaccines, partnerships with public health organizations, and targeting the neglected communities.
• Expanding access to vaccines: There is a great opportunity for growth in the Access to vaccines to expanding access in the whooping cough preventable vaccine market. The initiatives to promote vaccine deployment in the most densely inhabited low and middle-income countries have the highest potential of benefitting many people. Mobile vaccination clinics and community outreach programs are some of the strategies for reaching out to at-risk communities and making sure that all who need the most important whooping cough inoculation can do so.
• The use of technology within education and outreach: The usage of technology for education and outreach represents a huge growth potential in the whooping cough preventable vaccine market. Information regarding the benefits of vaccination or the common problems related to it can be effectively provided through digital media and mobile applications. Health organizations can reach the community through the use of social media and other online means and help reduce vaccine hesitancy and subsequently increase the rate of vaccination among the intended populations.
• Introduction of combination vaccines: The introduction of combination vaccines presents great opportunities for improving immunization against whooping cough. Such vaccines enable protection against several diseases with just one injection which eases the number of injections a person requires and improves compliance. They can develop more combination products that will have pertussis protection hence relieving parents of many visits to the health facility for immunizations and easing the immunization schedule for children.
• Increasing collaboration with public health organizations: Increasing collaboration with public health organizations is very important for the market growth for the whooping cough vaccine. Government workload coordination between NGOs and international health Organizations themselves helps to increase vaccination programs funding and improve the immunization programs. Such partnerships help in resource management and sharing of knowledge to promote diseases fight plans against whooping cough and improve strategies to fight against other health problems.
• Targeting underserved populations: Targeting underserved populations is a key area of growth in the whooping cough preventable vaccine market. Well target programs that are geared towards mitigating the peculiar barriers confronted by those communities can bring about enhanced vaccination rates. Such healthcare strategies ensure that these individuals receive education, access, and support which will lead to their timely immunization against whooping cough, which is critical if the prevalence of the disease is to be reduced.
Such strategic growth opportunities are changing the scope of the whooping cough preventable vaccine market by enhancing immunization accessibility, increasing awareness and education about the disease and the vaccine as well as creating synergies among the stakeholders. Targeting and addressing the needs of the unattached population and devising creative ways to this population will increase uptake of the vaccine and the incidence of whooping cough among the population will be low. The result is that these activities improve the health and well-being of the population and avert the occurrence of health emergencies.
Whooping Cough Preventable Vaccine Market Driver and Challenges
The whooping cough preventable vaccine market has its drivers and challenges affecting its growth and efficiency. Growth in a populace with improved public knowledge and exposure to vaccines, improved health programs, herd immunity strategies, effective vaccine promotion, and dependable legislation are clues to the forefront of the market. On the other hand, difficulties are posed by vaccine hesitation, high costs, availability, under-vaccination, and wrong information.
The factors responsible for driving the whooping cough preventable vaccine market include:
1. Advancements in vaccine technology: Vaccine technology advancements are a profound contributor to the whooping cough-preventable vaccine market. The introduction of plant-manufactured and more comfortable vaccines improved the acceptance and compliance of vaccination schedules. Marketed combination vaccines increase efficiency, lowering the number of injections due to the necessity of a lower number of vaccines resulting in to increase in vaccination coverage.
2. Improved health education: Improving health education is necessary in promoting vaccine for pertussis. Health governments introduce activities that help society understand the degree of risk that this disease poses, as well as the necessity to get vaccinated. These efforts are of great importance especially when there are outbreaks of the disease or when the disease is common.
3. Encouragement for herd immunity: Focus on herd immunity is very crucial in driving the whooping cough preventable vaccine market. Immunity however may not be obtained by vaccination for certain individuals including very young infants and persons with some medical conditions. There are public health measures emphasizing the need of vaccination for the protection of communities which are increasing.
4. Increasing changing awareness about vaccine importance: As stated earlier, the growing changing awareness about vaccine importance is directly affecting the whooping cough-preventable vaccine market. Health awareness campaigns, information education, communication strategies, and even the media possess the key factor of modifying the knowledge of the people concerning the disease of whooping cough and the measures of vaccinating people against it.
5. Supportive regulatory frameworks: Supportive regulatory frameworks work to the advantage of the whooping cough preventable vaccine market. Governments and health authorities are putting in place policies that encourage vaccination such as budgeting for vaccination programs and health education campaigns. Further, such procedures concerning approval of novel vaccines which are low in administration promote the market of new product generation.
Challenges in the whooping cough preventable vaccine market are:
1. Vaccine hesitancy: Vaccine hesitancy remains a significant challenge in the whooping cough preventable vaccine market. Misinformation and fear surrounding vaccine safety can lead to delays or refusals in vaccination, ultimately affecting herd immunity. Public health organizations must actively combat vaccine hesitancy by providing clear and accurate information, engaging with communities, and addressing concerns.
2. High costs: High cost of vaccination can affect saving a life from coughs diseases especially in low- and medium-income countries. Affordability challenges can lead to inequitable distribution of vaccine usage whereby majority of the population at risk are left with no protection.
3. Accessibility issues: It has to be noted that accessibility issues are an area of concern in the whooping cough preventable vaccine market. Geographical, socioeconomic, and logistical factors can prohibit vaccine delivery and uptake, especially in marginalized groups. It is obvious, however, that these challenges need to be tackled by coming up with creative solutions such as mobile vaccination units or outreach programs for the vaccines to be placed in the most strategic locations.
The drivers and challenges which affect the whooping cough preventable vaccine market also have an overall influence on the course of that market bringing in things to be provided afterward. On the one hand, technological advancement, enhancement of the public health measures, and raising of the level of society help in the growth of the market. On the other hand, vaccine hesitation and accessibility hurdles work against the advance.
List of Whooping Cough Preventable Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies whooping cough preventable vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whooping cough preventable vaccine companies profiled in this report include-
• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma
• KM Biologics
• Wuhan Institute Of Biological Products
• Walvax Biotechnology
• Chengdu Institute Of Biological Products
Whooping Cough Preventable Vaccine by Segment
The study includes a forecast for the global whooping cough preventable vaccine market by type, application, and region.
Whooping Cough Preventable Vaccine Market by Type [Analysis by Value from 2018 to 2030]:
• Acellular Vaccines
• Whole-Cell Vaccines
Whooping Cough Preventable Vaccine Market by Application [Analysis by Value from 2018 to 2030]:
• 12 Months Below
• 12 Months Above
Whooping Cough Preventable Vaccine Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Whooping Cough Preventable Vaccine Market
There has been a growing vaccine market for the whooping cough disease because health authorities across the globe have put measures to avert the infectious disease that is on the rise again. The growing awareness about the necessity of vaccination, the emergence of better-performing vaccines, and health policies affect the future market. Regions like the USA, China, Germany, India, and Japan are putting low efforts into increasing the coverage of the whooping cough vaccine and devising new policies to make the whooping cough vaccine more potent, which should not be the case.
• US: The market has given way to the production and approval of combination vaccines that impart a precaution for more than one disease. Vaccination is being promoted through various public health campaigns especially during pregnancy and for infants on the whooping cough vaccine. Additionally, there has been pressure to vaccinate teenagers and grown-ups to achieve herd immunity and this has led to more acceptance and availability of the whooping cough vaccine.
• China: The country under review has successfully advanced in the whooping cough vaccination campaign, particularly in the expansion of immunization coverage at the rural-urban interface. Recent efforts from the government are geared towards educating and enlightening the public concerning the disease and the need to be vaccinated against it. Furthermore, increased capability in the production of vaccines and working with global health institutions are also aiding in better provision and effectiveness of vaccination against this disease which is entirely preventable.
• Germany: Germany’s whooping cough vaccination campaigns seem to be improved too considering the use of more public health campaigns and more recent guidelines for immunization services. Health authorities in Germany have backed the administration of combination vaccines, which immunize against pertussis along with other diseases. At the same time, the emphasis has been placed on increasing booster vaccination coverage rates among adolescents and adults, particularly among healthcare workers, in the community to prevent whooping cough outbreaks and sustain herd immunity.
• India: In India, it was noted that in the recent past, greater emphasis has been laid on improving accessibility to whooping cough vaccination services both in the urban and rural areas. The GovernmentÄX%$%Xs undertakings are focusing on strengthening the immunization programs and educating people on the need to get vaccinated on time. Some of the initiatives include working with NGOs and WHO to provide vaccines and alleviate the problem of whooping cough which has been ravaging the country, especially among children below the age of five years.
• Japan: About the whooping cough vaccination program Japan has rolled out new strategies on how the program is going to work notably how adults can be assisted to boost the uptake of the primary booster doses. Parents are being addressed through the programs to alert them of the risk of whooping cough as well as the need to vaccinate babies and children. Also, the authorities are exploring vaccine development for sustained improvement of existing vaccines for better control of the disease.
Features of the Global Whooping Cough Preventable Vaccine Market
Market Size Estimates: Whooping cough preventable vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Whooping cough preventable vaccine market size by type, application, and region in terms of value ($B).
Regional Analysis: Whooping cough preventable vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the whooping cough preventable vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whooping cough preventable vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the growth forecast for whooping cough preventable vaccine market?
Answer: The global whooping cough preventable vaccine market is expected to grow with a CAGR of 3.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the whooping cough preventable vaccine market?
Answer: The major drivers for this market are increasing awareness of vaccination importance, rising incidence of whooping cough globally, and growing advancements in vaccine technology for improved efficacy.
Q3. What are the major segments for whooping cough preventable vaccine market?
Answer: The future of the whooping cough preventable vaccine market looks promising with opportunities in the acellular vaccine and whole-cell vaccine markets.
Q4. Who are the key whooping cough preventable vaccine market companies?
Answer: Some of the key whooping cough preventable vaccine companies are as follows:
• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma
• KM Biologics
• Wuhan Institute Of Biological Products
• Walvax Biotechnology
• Chengdu Institute Of Biological Products
Q5. Which whooping cough preventable vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that 12 months below is expected to witness higher growth over the forecast period.
Q6. In whooping cough preventable vaccine market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the whooping cough preventable vaccine market by type (acellular vaccines and whole-cell vaccines), application (12 months below and 12 months above), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?